Literature DB >> 20689546

A needle in the 'cancer vaccine' haystack.

Anne Gallois, Nina Bhardwaj.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20689546     DOI： 10.1038/nm0810-854

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  15 in total

Review 1.  Directing dendritic cell immunotherapy towards successful cancer treatment.

Authors:  Rachel Lubong Sabado; Nina Bhardwaj
Journal:  Immunotherapy       Date:  2010-01       Impact factor: 4.196

Review 2.  The CD8+ dendritic cell subset.

Authors:  Ken Shortman; William R Heath
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

3.  Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells.

Authors:  Lionel Franz Poulin; Mariolina Salio; Emmanuel Griessinger; Fernando Anjos-Afonso; Ligia Craciun; Ji-Li Chen; Anna M Keller; Olivier Joffre; Santiago Zelenay; Emma Nye; Alain Le Moine; Florence Faure; Vincent Donckier; David Sancho; Vincenzo Cerundolo; Dominique Bonnet; Caetano Reis e Sousa
Journal:  J Exp Med       Date:  2010-05-17       Impact factor: 14.307

4.  Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells.

Authors:  Annabell Bachem; Steffen Güttler; Evelyn Hartung; Frédéric Ebstein; Michael Schaefer; Astrid Tannert; Abdulgabar Salama; Kamran Movassaghi; Corinna Opitz; Hans W Mages; Volker Henn; Peter-Michael Kloetzel; Stephanie Gurka; Richard A Kroczek
Journal:  J Exp Med       Date:  2010-05-17       Impact factor: 14.307

5.  Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.

Authors:  Sarah L Jongbloed; Andrew J Kassianos; Kylie J McDonald; Georgina J Clark; Xinsheng Ju; Catherine E Angel; Chun-Jen J Chen; P Rod Dunbar; Robert B Wadley; Varinder Jeet; Annelie J E Vulink; Derek N J Hart; Kristen J Radford
Journal:  J Exp Med       Date:  2010-05-17       Impact factor: 14.307

6.  IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.

Authors:  Peter Dubsky; Hiroaki Saito; Marylene Leogier; Carole Dantin; John E Connolly; Jacques Banchereau; A Karolina Palucka
Journal:  Eur J Immunol       Date:  2007-06       Impact factor: 5.532

7.  alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity.

Authors:  Robbie B Mailliard; Anna Wankowicz-Kalinska; Quan Cai; Amy Wesa; Catharien M Hilkens; Martien L Kapsenberg; John M Kirkwood; Walter J Storkus; Pawel Kalinski
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

8.  Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin.

Authors:  David Sancho; Diego Mourão-Sá; Olivier P Joffre; Oliver Schulz; Neil C Rogers; Daniel J Pennington; James R Carlyle; Caetano Reis e Sousa
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

9.  Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells.

Authors:  Brigitte G Dorner; Martin B Dorner; Xuefei Zhou; Corinna Opitz; Ahmed Mora; Steffen Güttler; Andreas Hutloff; Hans W Mages; Katja Ranke; Michael Schaefer; Robert S Jack; Volker Henn; Richard A Kroczek
Journal:  Immunity       Date:  2009-11-12       Impact factor: 31.745

10.  Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells.

Authors:  Kira Minkis; Daniel G Kavanagh; Galit Alter; Dusan Bogunovic; David O'Neill; Sylvia Adams; Anna Pavlick; Bruce D Walker; Mark A Brockman; Rajesh T Gandhi; Nina Bhardwaj
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701
View more
  5 in total

Review 1.  Dendritic cell-targeted approaches to modulate immune dysfunction in the tumor microenvironment.

Authors:  Anne Gallois; Nina Bhardwaj
Journal:  Front Immunol       Date:  2013-12-10       Impact factor: 7.561

2.  Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells.

Authors:  Sreekumar Balan; Vincent Ollion; Nicholas Colletti; Rabie Chelbi; Frédéric Montanana-Sanchis; Hong Liu; Thien-Phong Vu Manh; Cindy Sanchez; Juliette Savoret; Ivan Perrot; Anne-Claire Doffin; Even Fossum; Didier Bechlian; Christian Chabannon; Bjarne Bogen; Carine Asselin-Paturel; Michael Shaw; Timothy Soos; Christophe Caux; Jenny Valladeau-Guilemond; Marc Dalod
Journal:  J Immunol       Date:  2014-07-09       Impact factor: 5.422

3.  Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals.

Authors:  Víctor Casanova; Isaac Naval-Macabuhay; Marta Massanella; Marta Rodríguez-García; Julià Blanco; José M Gatell; Felipe García; Teresa Gallart; Carme Lluis; Josefa Mallol; Rafael Franco; Núria Climent; Peter J McCormick
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

Review 4.  Investigating Evolutionary Conservation of Dendritic Cell Subset Identity and Functions.

Authors:  Thien-Phong Vu Manh; Nicolas Bertho; Anne Hosmalin; Isabelle Schwartz-Cornil; Marc Dalod
Journal:  Front Immunol       Date:  2015-06-02       Impact factor: 7.561

5.  Immunogenicity of targeted lentivectors.

Authors:  Cleo Goyvaerts; De Groeve Kurt; Sandra Van Lint; Carlo Heirman; Jo A Van Ginderachter; Patrick De Baetselier; Geert Raes; Kris Thielemans; Karine Breckpot
Journal:  Oncotarget       Date:  2014-02-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.